1- Mion F pour Société Nationale Française de GastroEntérologie, Groupe Français de Neuro-Gastroentérologie. Prise en charge de la dyspepsie. Fév 2014. Disponible sur www.snfge.org/content/cp013-prise-en-charge-de-la-dyspepsie
2- Talley NJ et al. Guidelines for the management of dyspepsia. Am J Gastroenterol 2005; 100: 2324-37
3- Zagari RM, Fuccio L, Bazzoli F. Investigating dyspepsia. BMJ. 2008 Sep 15;337
4- Veldhuyzen van Zanten SJO, Chiba N, Armstrong D et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: The CADET-HN Study. Am J Gastroenterol 2005;100:1477-88
5- INAMI. L’usage adéquat des inhibiteurs d’acide dans le reflux gastro-œsophagien et la dyspepsie. Réunion de consensus 15 mai 2003. Disponible sur http://www.facm.ucl.ac.be/cours/Van-Bambeke/FARM22/2004-2005/guidelines…
6- Jian R. Dyspepsie : explorer ou traiter ? Cours pour le DES de Gastro-entérologie. 2010. Disponible sur http://hepatoweb.com/DES/exposes/DES_16012010_COFFIN/JIAN.pdf
7- Richard-Molard M. Dyspepsie chronique idiopathique. Séminaire de Tursac. Octobre 2006. Disponible sur http://hepatoweb.com/DES/DES_GO/SEMINAIRE_102006/DYSPEPSIE.pdf
8- Ford AC, Qume M, Moayyedi P, Arents NL, Lassen AT, Logan RF, McColl KE, Myres P, Delaney BC. Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis. Gastroenterology. 2005 Jun;128(7):1838-44
9- Lassen AT et al. Helicobacter pylori test and eradicate versus prompt endoscopy for management of dyspeptic patients: 6.7 year follow up of a randomised trial. Gut 2004;53:1758-1763
10- Vakil N, Talley N, van Zanten SV, Flook N, Persson T, Björck E, Lind T, Bolling-Sternevald E; STARS I Study Group. Cost of detecting malignant lesions by endoscopy in 2741 primary care dyspeptic patients without alarm symptoms. Clin Gastroenterol Hepatol. 2009 Jul;7(7):756-61
11- Holtmann G, Talley NJ, Liebregts T et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006 ; 354 : 832-40
12- Mc Coll Ket al.Symptomatic benefit from eradicating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998;339:1869-74.
13- Blum AL et al. Lack of effect of treating Helicobacter pylori infection in patients with non-ulcer dyspepsia. N Engl J Med 1998 ;339:1875-81.
14- Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology. 2002 Dec;123(6):1778-85
15- Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection – The Maastricht III Consensus Report. Gut 2007
16- Humair JP, Iliescu I. Dyspepsie. 2009. Disponible sur www.hug-ge.ch/sites/interhug/files/atelier_mpr/090204_Dyspepsie.ppt
17- Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90
18- Moayyedi P, Soo S, Deeks JJ et al. Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD002096
19- Hôpitaux universitaires de Genève. Dyspepsie. 2010. Disponible sur http://www.hug-ge.ch/sites/interhug/files/structures/medecine_de_premie…
20- Bytzer P. Dyspepsia as an adverse effect of drugs. Best Pract Res Clin Gastroenterol 2010;24:109-20
21- Von Marrewijk CJ, Mujakovic S, Fransen GA, et al. Effect and costeffectiveness of step-up versus stepdown treatment with antacids, H2 receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. Lancet 2009;373:215-25
22- Bruley des Varannes S. Prise en charge de la dyspepsie fonctionnelle. Journées Francophones d’Hépato-gastroentérologie et d’Oncologie Digestive 2011 . Disponible sur http://www.fmcgastro.org/wp-content/uploads/file/ppt-2011/305_Stanislas…
23- Chiba N, Veldhuyzen van Zanten SJ, Sinclair P et al. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment - H pylori (CADET-Hp) randomised controlled trial. BMJ 2002;324:1012-6
24-Moayyedi P, Shelly S, Deeks JJ, Delaney B, Innes M, Forman D. WITHDRAWN:Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2011 Feb 16;(2):CD001960
25- Harvey RF, Lane JA, Nair P, et al. Clinical trial: prolonged beneficial effect of Helicobacter pylori eradication on dyspepsia consultations - the Bristol Helicobacter Project. Aliment Pharmacol Ther 2010;32:394-400
26- Ford AC, Forman D, Bailey AG, et al. A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial. Gastroenterology 2005;129:1910-7.
27- Bazzoli F. Key points from the revised Maastricht Consensus Report: the impact on general practice. Eur J Gastroenterol Hepatol. 2001 Aug;13 Suppl 2:S3-7
28- Mertz H, Fass R, Kodner A, et al. Effect of amitryptiline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998;93:160-5
Étude & Pratique
Pas d’aspirine chez le coronarien stenté déjà anticoagulé
En 5 points
Le refus scolaire anxieux
Mise au point
Prise en charge de la goutte en 2025
Mise au point
Le prurit